Biotechnology Acquisitions in New Hampshire
Showing 1 transactions.
-
December 13, 2023
- Buyer
- Windjammer Capital Investors
- Target
- Bio X Cell
- Industry
- Biotechnology
- Location
- New Hampshire, United States
- Type
- Buyout
Windjammer Capital Investors completed a control acquisition of Bio X Cell, a producer of monoclonal antibodies for pre-clinical research, in a transaction that closed November 6, 2023. Windjammer said it will partner with management to accelerate organic growth and pursue a thesis-driven acquisition strategy to expand Bio X Cell's addressable market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.